<DOC>
	<DOCNO>NCT02856347</DOCNO>
	<brief_summary>The aim trial study radiate diagnosis agent use post surgery biological assessment highlight residual disease . This inter-regional multicentric , prospective study evaluate benefit PET F-DOPA image involved node detection compare standard image assessment patient medullary thyroid cancer . The purpose study evaluate impact performance new PET / CT ( computerized tomography ) tracer target dopamine receptor patient residual ganglionar biological disease initial surgery medullary thyroid cancer compare standard imaging . Obtained data compare `` gold standard '' base : - node cytology could puncture - histology new surgery recommend - surveillance 2 first case applicable ( image monitoring , evolution thyrocalcitonin )</brief_summary>
	<brief_title>Prospective Study Evaluating Medullary Thyroid Cancer Management 's Care Using PET F-DOPA Patients With High Level Postoperative Residual Thyrocalcitonin</brief_title>
	<detailed_description />
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Neuroendocrine</mesh_term>
	<mesh_term>Dihydroxyphenylalanine</mesh_term>
	<mesh_term>Salmon calcitonin</mesh_term>
	<mesh_term>Calcitonin</mesh_term>
	<mesh_term>Calcitonin Gene-Related Peptide</mesh_term>
	<criteria>1 . Age &gt; = 18 year . 2 . Patient medullary thyroid cancer ( sporadic hereditary form ) . 3 . Patient treat total thyroidectomy uni bilateral lymph node dissection ( central and/or lateral neck compartment ) . 4 . Patient elevate thyrocalcitonin rate &gt; = 150 pg/ml assess within 6 week surgery . 5 . Patient standard image assessment perform 3 month PET 18FDOPA . 6 . Standard image assessment include least cervical ultrasound , cervicothoracic CTscan and/or cervicothoracoabdominopelvic CTscan liver MRI . 7 . Patient able follow least 6 month PET 18FDOPA . 8 . If woman breastfeed , nurse discontinue 24 hour PET 18FDOPA . 9 . Patient must provide write informed consent prior specific procedure assessment . 10 . Patient must affiliate French Social Security System . 1 . Pregnant patient . 2 . Postoperative radiotherapy initiate PET 18FDOPA . 3 . Patient PET 18FDG perform within 24 hour PET 18FDOPA . 4 . Participation clinical trial therapeutic use . 5 . Patient PET / CTscan exam contraindication . 6 . Any serious and/or unstable preexist psychological , familial , geographic social condition could interfere medical followup compliance study procedure . 7 . Patient protect law .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Medullary Thyroid Cancer</keyword>
	<keyword>PET F-DOPA</keyword>
	<keyword>18-FDOPA</keyword>
</DOC>